The Despair of Persons Living With Alzheimer’s Disease

By Jason Karlawish On the morning of June 7th, 2021, the U.S. Food and Drug Administration (FDA) approved Biogen’s drug aducanumab (marketed as Aduhelm) for the treatment of Alzheimer’s disease. Alzheimer’s Association President Harry Johns called this decision “historic.” For … Read the article The post The Despair of Persons Living With Alzheimer’s Disease appeared […]

Read More

By Jason Karlawish

On the morning of June 7th, 2021, the U.S. Food and Drug Administration (FDA) approved Biogen’s drug aducanumab (marketed as Aduhelm) for the treatment of Alzheimer’s disease. Alzheimer’s Association President Harry Johns called this decision “historic.” For … Read the article

The post The Despair of Persons Living With Alzheimer’s Disease appeared first on The History Reader.

Related Posts

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

%d bloggers like this: